Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Onyx Pharmaceuticals has appointed Matthew Fust as its new executive vice president and CFO, effective January 5, 2009. In this role, Mr Fust will serve as Onyx's principal financial and accounting officer and report to Anthony Coles, Onyx's president and CEO.
Subscribe to our email newsletter
Most recently, Mr Fust was executive vice president and CFO at Jazz Pharmaceuticals, which he joined in 2003. From 2002 until 2003, he was CFO at Perlegen Sciences. Previously, Mr Fust was senior vice president and CFO at Alza where he was an executive from 1996 until 2002.
Dr Coles said: “Matt is a proven leader who brings extensive senior management and operational experience to Onyx, as well as a shared strategic vision to create a leading biopharmaceutical company.
“His demonstrated capabilities in implementing corporate and financial strategies and accelerating corporate growth have been reflected throughout his career. On behalf of the board and the other members of the executive team, it is a pleasure to welcome Matt.”